1. Describe relationships between markers of CKD severity and outcomes.
2. Weigh accumulating evidence for novel biomarkers for CKD and CVD in patients with CKD and kidney transplant recipients.
Thursday, September 27, 2018 - 1:00pm to 2:00pm
Brad Astor, PhD, MPH
UCMC AMB S-534
Chicago, IL 60637
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation